XML 31 R20.htm IDEA: XBRL DOCUMENT v3.19.1
Stock-based Compensation (Tables)
3 Months Ended
Mar. 31, 2019
Share-based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity

A summary of stock option activity for the period ended March 31, 2019, is presented below:

 

    Number of     Weighted
Average
Exercise
    Weighted
Average
    Aggregate
Intrinsic
 
Subject to Exercise   Options     Price     Life (Years)     Value  
Outstanding as of December 31, 2018     843,648     $ 16.43       6.56     $ -  
Granted – 2019     54,909     $ 0.94       10.00       -  
Forfeited – 2019     -       -       -       -  
Exercised – 2019     -       -       -       -  
Outstanding as of March 31, 2019     898,557     $ 15.48       6.53     $ -  

Schedule of Outstanding Stock Options

As of March 31, 2019, the Company had outstanding stock options as follows:

 

Date Issued   Exercise Price     Number of Options     Expiration date
September 2014   $ 15.90       58,307     December 27, 2025
November 2014   $ 15.90       17,492     December 27, 2025
August 2015   $ 15.90       312,180     December 27, 2025
September 2015   $ 15.90       20,000     December 27, 2025
November 2015   $ 15.90       122,464     December 27, 2025
December 2015   $ 15.90       80,275     December 27, 2025
January 2016   $ 15.90       127,581     January 9, 2026
March 2016   $ 20.50       5,400     February 24, 2021
May 2016   $ 20.50       80,744     May 26, 2026
September 2016   $ 20.50       9,933     May 31, 2026
January 2017   $ 20.50       5,356     January 1, 2027
January 2018   $ 19.70       3,916     January 1, 2028
January 2019   $ 0.94       54,909     January 1, 2029
                     
Total outstanding options at March 31, 2019             898,557      

Schedule of Assumptions Using Black-Scholes Option Pricing Model

The Company utilized the Black-Scholes option pricing model. The assumptions used for the periods ended March 31, 2019 and 2018 are as follows:

 

    March 31, 2019     March 31, 2018  
Risk free interest rate     2.554 %     2.302%-2.659 %
Expected life (in years)     6.24       6.24-7.75  
Expected Volatility     169.87 %     169.33%-179.79 %
Expected dividend yield     0 %     0 %

Schedule of Non-vested Options

A summary of the changes in the Company’s non-vested options during the period ended March 31, 2019, is as follows:

 

    Number of
Non-vested
Options
    Weighted Average
Fair Value at
Grant Date
 
Non-vested at December 31, 2018     117,464     $ 14.61  
Granted in 2019     54,909     $ 0.91  
Forfeited – 2019     -     $ -  
Vested in 2019     13,727     $ 0.91  
Non-vested at March 31, 2019     158,646     $ 12.33  
Exercisable at March 31, 2019     739,911     $ 14.08  
Outstanding at March 31, 2019     898,557     $ 13.77